R&D
🇺🇸 FDA Page 3FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 25–36 of 117 articles
BioNTech doses first patient in Phase 1 pancreatic cancer mRNA vaccine trial
MariTide Phase 2 obesity data show up to 20% weight loss at one year
Danuglipron Phase 3 Watch After Pfizer’s Phase 2b Obesity Win
Novo Nordisk supply of Wegovy stabilizes as FDA shortage ends
Cobenfy meets endpoint in Bristol Myers Squibb’s Alzheimer’s psychosis trial
MariTide Phase 2: Amgen reports up to 20% weight loss at one year
Eli Lilly raises 2026 revenue guidance on Mounjaro demand
Merck’s Harpoon acquisition deepens oncology pipeline ahead of Keytruda risk
Pfizer's Danuglipron Hits Phase 2b Obesity Endpoint
Roche reports positive Phase 3 results for trontinemab in Alzheimer's disease
Triple Hormone-Receptor Agonist Retatrutide for Obesity: Phase 3 Results and Market Impact
Exclusive: FDA issues industry-friendly gene therapy guidance: What BD teams need to know